Instalok – 20 Injection
Established in 2019, Insight Medicare is a dynamic and fast-growing Indian pharmaceutical company headquartered in Mumbai.
Instalok – 20 Injection
Category :Gastro
Instalok-20 is a fast-acting proton pump inhibitor injection containing Rabeprazole Sodium, used for the treatment of acid-related disorders such as GERD, Zollinger-Ellison syndrome, and gastric ulcers when oral therapy is not possible.
Product Description
Compositions:
Rabeprazole 20 mg. Injection
Key Ingredients & Benefits:
- Rabeprazole can achieve optimal acid suppression since the first administration and can malntaln this advantage in the following days of therapy”
- Possesses rapid onset of maximal acid suppression with greater Antiscrelory effect over a 24hr period.
- Shows greater Inhibition of gastric acid secretion than Omeprazole.
- Produces rapid inhibition of H.Pylori compared with Omeprazole and Lansoprazole.
- Reduces the frequency & Intensity of heart burn assoclated with ulcerative Oesophagitis in CERD.
- Ensure faster and easy stoppage of hyperacidity
Therapeutic Uses:
Rx in
- Active duodenal/gastric ulcer with bleeding or severe erosions
- GERD
- Acid aspiration.
- Stress-induced mucosal injury in critical care.
- -Pathological hypersecretory conditions, including Zollinger-Ellison syndrome
Related Products
